Cystic fibrosis lung environment and Pseudomonas aeruginosa infection

BackgroundThe airways of patients with cystic fibrosis (CF) are highly complex, subject to various environmental conditions as well as a distinct microbiota. Pseudomonas aeruginosa is recognized as one of the most important pulmonary pathogens and the predominant cause of morbidity and mortality in CF. A multifarious interplay between the host, pathogens, microbiota, and the environment shapes the course of the disease. There have been several excellent reviews detailing CF pathology, Pseudomonas and the role of environment in CF but only a few reviews connect these entities with regards to influence on the overall course of the disease. A holistic understanding of contributing factors is pertinent to inform new research and therapeutics.DiscussionIn this article, we discuss the deterministic alterations in lung physiology as a result of CF. We also revisit the impact of those changes on the microbiota, with special emphasis on P. aeruginosa and the influence of other non-genetic factors on CF. Substantial past and current research on various genetic and non-genetic aspects of cystic fibrosis has been reviewed to assess the effect of different factors on CF pulmonary infection. A thorough review of contributing factors in CF and the alterations in lung physiology indicate that CF lung infection is multi-factorial with no isolated cause that should be solely targeted to control disease progression. A combinatorial approach may be required to ensure better disease outcomes.ConclusionCF lung infection is a complex disease and requires a broad multidisciplinary approach to improve CF disease outcomes. A holistic understanding of the underlying mechanisms and non-genetic contributing factors in CF is central to development of new and targeted therapeutic strategies.

[1]  H. Coutinho,et al.  International Archives of Medicine BioMed Central Review , 2008 .

[2]  M. Surette,et al.  Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient , 2013, PloS one.

[3]  G. Döring,et al.  Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study , 2012, Thorax.

[4]  F. Baquero,et al.  Population Structure, Antimicrobial Resistance, and Mutation Frequencies of Streptococcus pneumoniae Isolates from Cystic Fibrosis Patients , 2005, Journal of Clinical Microbiology.

[5]  R. Homer,et al.  Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[6]  J. Widdicombe,et al.  CFTR and calcium-activated chloride channels in primary cultures of human airway gland cells of serous or mucous phenotype. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[7]  S. Lory,et al.  A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. , 2004, Developmental cell.

[8]  J. M. Sauder,et al.  Impact of the ΔF508 Mutation in First Nucleotide-binding Domain of Human Cystic Fibrosis Transmembrane Conductance Regulator on Domain Folding and Structure* , 2005, Journal of Biological Chemistry.

[9]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[10]  Denis Wirtz,et al.  Micro- and macrorheology of mucus. , 2009, Advanced drug delivery reviews.

[11]  D. Hartl,et al.  Update on host-pathogen interactions in cystic fibrosis lung disease , 2016, Molecular and Cellular Pediatrics.

[12]  C. Basbaum,et al.  The serous cell. , 1990, Annual review of physiology.

[13]  A. Glanville,et al.  The spectrum of mycobacterial infection after lung transplantation. , 1999, American journal of respiratory and critical care medicine.

[14]  S. Bell,et al.  Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis , 2015, PloS one.

[15]  D. Sheppard,et al.  Gating of the CFTR Cl− channel by ATP‐driven nucleotide‐binding domain dimerisation , 2009, The Journal of physiology.

[16]  P. Hiatt,et al.  Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[17]  Jeffrey L. Curtis,et al.  Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals , 2015, mBio.

[18]  Á. Mészáros,et al.  Health Related Quality of Life of Children with Chronic Respiratory Conditions. , 2015, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[19]  Kai Du,et al.  Cooperative assembly and misfolding of CFTR domains in vivo. , 2009, Molecular biology of the cell.

[20]  L. Delhaes,et al.  Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. , 2009, Medical mycology.

[21]  W. Meyer,et al.  Fungal infections and treatment in cystic fibrosis , 2013, Current opinion in pulmonary medicine.

[22]  G. McLennan,et al.  Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children. , 2010, American journal of respiratory and critical care medicine.

[23]  J. Heesemann,et al.  Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment. , 2014, International journal of medical microbiology : IJMM.

[24]  Emily Newman,et al.  Self-Esteem and Its Relationship to Mental Health and Quality of Life in Adults with Cystic Fibrosis , 2013, Journal of Clinical Psychology in Medical Settings.

[25]  R. Vance,et al.  Recognition of bacteria by inflammasomes. , 2013, Annual review of immunology.

[26]  R. Boucher,et al.  CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship , 1993, Nature.

[27]  M. Schöni,et al.  Nutrition and lung function in cystic fibrosis patients: review. , 2000, Clinical nutrition.

[28]  L. Hoffman,et al.  Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience , 2012, Thorax.

[29]  P. Reix,et al.  Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[30]  R. Castile,et al.  Structural airway abnormalities in infants and young children with cystic fibrosis. , 2004, The Journal of pediatrics.

[31]  E. Sorscher,et al.  CFTR involvement in chloride, bicarbonate, and liquid secretion by airway submucosal glands. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[32]  S. Ballard,et al.  Liquid secretion properties of airway submucosal glands , 2004, The Journal of physiology.

[33]  Y. Kong,et al.  Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium , 2015, Nature Communications.

[34]  Zhengrong Yang,et al.  Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis , 2010, Protein science : a publication of the Protein Society.

[35]  M. Valvano,et al.  Depletion of the Ubiquitin-binding Adaptor Molecule SQSTM1/p62 from Macrophages Harboring cftr ΔF508 Mutation Improves the Delivery of Burkholderia cenocepacia to the Autophagic Machinery* , 2012, The Journal of Biological Chemistry.

[36]  M. Kosorok,et al.  Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. , 1997, Pediatrics.

[37]  M. Surette,et al.  Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections , 2016, PloS one.

[38]  D. Benos,et al.  CFTR regulation of epithelial sodium channel. , 2011, Methods in molecular biology.

[39]  J. Carlin,et al.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. , 2001, The Journal of pediatrics.

[40]  M. Surette,et al.  Inactivation of MuxABC-OpmB transporter system in Pseudomonas aeruginosa leads to increased ampicillin and carbenicillin resistance and decreased virulence , 2011, The Journal of Microbiology.

[41]  V. Vallon,et al.  Molecular Mechanisms of Calcium-sensing Receptor-mediated Calcium Signaling in the Modulation of Epithelial Ion Transport and Bicarbonate Secretion* , 2014, The Journal of Biological Chemistry.

[42]  M. Welsh Cigarette smoke inhibition of ion transport in canine tracheal epithelium. , 1983, The Journal of clinical investigation.

[43]  C. Schultz,et al.  Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease , 2016, Molecular and Cellular Pediatrics.

[44]  M. Kuehn,et al.  Naturally Produced Outer Membrane Vesicles from Pseudomonas aeruginosa Elicit a Potent Innate Immune Response via Combined Sensing of Both Lipopolysaccharide and Protein Components , 2010, Infection and Immunity.

[45]  L. Dupont,et al.  Treatment burden in patients with at least one class IV or V CFTR mutation , 2015, Pediatric pulmonology.

[46]  C. Reilly,et al.  Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[47]  M. Schechter Non-Genetic Influences on Cystic Fibrosis Lung Disease: The Role of Sociodemographic Characteristics, Environmental Exposures, and Healthcare Interventions , 2003, Seminars in respiratory and critical care medicine.

[48]  S. Lynch,et al.  The cystic fibrosis airway microbiome. , 2013, Cold Spring Harbor perspectives in medicine.

[49]  T. Stockner,et al.  Pharmacological correction of misfolding of ABC proteins☆ , 2014, Drug discovery today. Technologies.

[50]  Q. Wang,et al.  Neutrophils sense microbial size and selectively release neutrophil extracellular traps in response to large pathogens , 2014, Nature Immunology.

[51]  L. Raskin,et al.  Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples , 2016, PloS one.

[52]  L. G. Johnson,et al.  Gene therapy for cystic fibrosis. , 1995, Chest.

[53]  T. Biedermann,et al.  Invariant Natural Killer T (iNKT) Cells Prevent Autoimmunity, but Induce Pulmonary Inflammation in Cystic Fibrosis , 2014, Cellular Physiology and Biochemistry.

[54]  S. Sagel,et al.  The airway microbiome in cystic fibrosis and implications for treatment , 2011, Current opinion in pediatrics.

[55]  J. Wine,et al.  Airway Gland Structure and Function. , 2015, Physiological reviews.

[56]  Christian Cambillau,et al.  Architecture and assembly of the Type VI secretion system. , 2014, Biochimica et biophysica acta.

[57]  M. Amaral,et al.  Deletion of Phe508 in the first nucleotide‐binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone , 2009, The FEBS journal.

[58]  Zhengrong Yang,et al.  Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide‐binding domain 1 , 2010, Protein science : a publication of the Protein Society.

[59]  G. Cutting,et al.  Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study , 2014, BMC Pulmonary Medicine.

[60]  Lian-Hui Zhang,et al.  Cis-2-dodecenoic acid signal modulates virulence of Pseudomonas aeruginosa through interference with quorum sensing systems and T3SS , 2013, BMC Microbiology.

[61]  S. Ye,et al.  Pseudomonas aeruginosa Cif Protein Enhances the Ubiquitination and Proteasomal Degradation of the Transporter Associated with Antigen Processing (TAP) and Reduces Major Histocompatibility Complex (MHC) Class I Antigen Presentation* , 2013, The Journal of Biological Chemistry.

[62]  S. Lory,et al.  Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Curtis,et al.  Application of a Neutral Community Model To Assess Structuring of the Human Lung Microbiome , 2015, mBio.

[64]  M. Schechter Wealth as a disease modifier in cystic fibrosis. , 2013, The Lancet Respiratory Medicine.

[65]  H. Gendelman,et al.  Cell delivery of therapeutic nanoparticles. , 2011, Progress in molecular biology and translational science.

[66]  D. Leduc,et al.  Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity , 2014, Nature Communications.

[67]  G. Dubourg,et al.  Microbiota manipulation for weight change. , 2017, Microbial pathogenesis.

[68]  Eoin L. Brodie,et al.  Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa , 2006, Journal of Clinical Microbiology.

[69]  J. Wakefield,et al.  Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. , 2015, Annals of the American Thoracic Society.

[70]  B. Tümmler,et al.  The cystic fibrosis lower airways microbial metagenome , 2016, ERJ Open Research.

[71]  N. Joo,et al.  Submucosal glands and airway defense. , 2004, Proceedings of the American Thoracic Society.

[72]  F. Jerry Reen,et al.  A new regulator of pathogenicity (bvlR) is required for full virulence and tight microcolony formation in Pseudomonas aeruginosa. , 2014, Microbiology.

[73]  S. Sagel,et al.  Cystic fibrosis: a model system for precision medicine , 2016, Current opinion in pediatrics.

[74]  S. D. Davidson Ward,et al.  Effect of residential proximity to major roadways on cystic fibrosis exacerbations , 2013, International journal of environmental health research.

[75]  Scott R. Miller,et al.  Genotypic and Phenotypic Variation in Pseudomonas aeruginosa Reveals Signatures of Secondary Infection and Mutator Activity in Certain Cystic Fibrosis Patients with Chronic Lung Infections , 2011, Infection and Immunity.

[76]  I. Novak,et al.  Purinergic regulation of CFTR and Ca(2+)-activated Cl(-) channels and K(+) channels in human pancreatic duct epithelium. , 2013, American journal of physiology. Cell physiology.

[77]  S. Donaldson,et al.  Lung microbiota across age and disease stage in cystic fibrosis , 2015, Scientific Reports.

[78]  D. Goodlett,et al.  A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. , 2010, Cell host & microbe.

[79]  Adrian W. R. Serohijos,et al.  Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel function , 2008, Proceedings of the National Academy of Sciences.

[80]  R. Castile,et al.  Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis , 2015, Pediatric pulmonology.

[81]  M. Corey,et al.  High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial. , 2007, The Journal of pediatrics.

[82]  K. Hamilton,et al.  Ion Channels and Transporters of Epithelia in Health and Disease , 2016, Physiology in Health and Disease.

[83]  D. Benos,et al.  The cytosolic termini of the beta- and gamma-ENaC subunits are involved in the functional interactions between cystic fibrosis transmembrane conductance regulator and epithelial sodium channel. , 2000, Journal of Biological Chemistry.

[84]  A. Hauser The type III secretion system of Pseudomonas aeruginosa: infection by injection , 2009, Nature Reviews Microbiology.

[85]  Michael G. Surette,et al.  Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections , 2008, PLoS pathogens.

[86]  D. Hartl,et al.  Current concepts of immune dysregulation in cystic fibrosis. , 2014, The international journal of biochemistry & cell biology.

[87]  D. Benos,et al.  The Cytosolic Termini of the β- and γ-ENaC Subunits Are Involved in the Functional Interactions between Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel , 2000 .

[88]  M. Karagas,et al.  Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis. , 2015, The Journal of pediatrics.

[89]  R. Turner,et al.  New developments in the epidemiology and clinical spectrum of rhinovirus infections , 2008, Current opinion in pediatrics.

[90]  J. Sturgess,et al.  A reconstruction of the duct system and secretory tubules of the human bronchial submucosal gland , 1969, Thorax.

[91]  M. Wjst,et al.  Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis , 2014, Journal of Molecular Medicine.

[92]  G. Sawicki,et al.  Managing treatment complexity in cystic fibrosis: Challenges and Opportunities , 2012, Pediatric pulmonology.

[93]  Eoin L. Brodie,et al.  Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.

[94]  J. Adjemian,et al.  Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. , 2013, American journal of respiratory and critical care medicine.

[95]  A. Meinhart,et al.  Structural Insights into the Effector – Immunity System Tse1/Tsi1 from Pseudomonas aeruginosa , 2012, PloS one.

[96]  Jan Michiels,et al.  Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. , 2011, Journal of medical microbiology.

[97]  G. Pier,et al.  Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[98]  C. Bear,et al.  Facilitating Structure-Function Studies of CFTR Modulator Sites with Efficiencies in Mutagenesis and Functional Screening , 2015, Journal of biomolecular screening.

[99]  G. Kroemer,et al.  Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis , 2016, Molecular and Cellular Pediatrics.

[100]  J. Wells,et al.  Generating human intestinal tissues from pluripotent stem cells to study development and disease , 2015, The EMBO journal.

[101]  J. Lo-Guidice,et al.  Human airway mucin glycosylation: A combinatory of carbohydrate determinants which vary in cystic fibrosis , 2001, Glycoconjugate Journal.

[102]  C. Goss,et al.  Tackling the increasing complexity of CF care , 2015, Pediatric pulmonology.

[103]  Atropine or Glycopyrrolate with Neostigmine 5 mg: A Comparative Dose-Response Study , 1986 .

[104]  Isabelle Callebaut,et al.  Molecular models of the open and closed states of the whole human CFTR protein , 2009, Cellular and Molecular Life Sciences.

[105]  C. Barry,et al.  Iron Acquisition and Metabolism by Mycobacteria , 1999, Journal of bacteriology.

[106]  Lars Kaderali,et al.  Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis , 2015, PloS one.

[107]  Philip J. Thomas,et al.  Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences , 2012, Cell.

[108]  J. Stroobant Viral infection in cystic fibrosis. , 1986, Journal of the Royal Society of Medicine.

[109]  Waldemar Vollmer,et al.  Type VI secretion delivers bacteriolytic effectors to target cells , 2011, Nature.

[110]  M. Henry,et al.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. , 2014, Blood.

[111]  D. Ohman,et al.  Identification of Genes in the σ22 Regulon of Pseudomonas aeruginosa Required for Cell Envelope Homeostasis in Either the Planktonic or the Sessile Mode of Growth , 2012, mBio.

[112]  R. Ramphal,et al.  Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing , 2012, Proceedings of the National Academy of Sciences.

[113]  R. Denny,et al.  Recent developments in targeting protein misfolding diseases. , 2013, Bioorganic & medicinal chemistry letters.

[114]  M. Surette,et al.  Hybrid sensor kinase PA1611 in Pseudomonas aeruginosa regulates transitions between acute and chronic infection through direct interaction with RetS , 2013, Molecular microbiology.

[115]  J. Beekman,et al.  Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis , 2012, Current opinion in pulmonary medicine.

[116]  R. Szczesniak,et al.  Adolescents' Spirituality and Cystic Fibrosis Airway Clearance Treatment Adherence: Examining Mediators. , 2016, Journal of pediatric psychology.

[117]  E. Alton,et al.  Gene therapy for cystic fibrosis: recent progress and current aims , 2016 .

[118]  M. Corboz,et al.  Effect of anion transport inhibition on mucus secretion by airway submucosal glands. , 1997, The American journal of physiology.

[119]  Richard Bonneau,et al.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.

[120]  N. Joo,et al.  Mucus Secretion from Single Submucosal Glands of Pig , 2002, The Journal of Biological Chemistry.

[121]  E. Mahenthiralingam Emerging cystic fibrosis pathogens and the microbiome. , 2014, Paediatric respiratory reviews.

[122]  G. Sawicki,et al.  Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[123]  Paola Vergani,et al.  CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains , 2005, Nature.

[124]  Alison Gifford,et al.  The role of neutrophils in cystic fibrosis , 2014, Current opinion in hematology.

[125]  A. Buckling,et al.  Pre‐adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates , 2016, Journal of evolutionary biology.

[126]  Sukhmani Kaur,et al.  Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment , 2016, Stem cells international.

[127]  A. Kharazmi,et al.  Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis , 2009, Thorax.

[128]  Ming Ding,et al.  Bone Formation by Sheep Stem Cells in an Ectopic Mouse Model: Comparison of Adipose and Bone Marrow Derived Cells and Identification of Donor-Derived Bone by Antibody Staining , 2016, Stem cells international.

[129]  S. Peltz,et al.  PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model , 2008, Proceedings of the National Academy of Sciences.

[130]  M. Welsh,et al.  Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung , 2012, Nature.

[131]  E. Bingen,et al.  Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization , 2001, Pediatric pulmonology.

[132]  A. Oliver Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy. , 2010, International journal of medical microbiology : IJMM.

[133]  T. DeSantis,et al.  The Microbial Community of the Cystic Fibrosis Airway Is Disrupted in Early Life , 2014, PloS one.

[134]  K. Cheung,et al.  Synergistic Effects of Cystic Fibrosis Transmembrane Conductance Regulator and Aquaporin-9 in the Rat Epididymis1 , 2003, Biology of reproduction.

[135]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.

[136]  D. Murphy,et al.  Ivacaftor in a G551D homozygote with cystic fibrosis. , 2013, The New England journal of medicine.

[137]  Yishan Luo,et al.  Staphylococcus aureus Inhibits IL-8 Responses Induced by Pseudomonas aeruginosa in Airway Epithelial Cells , 2015, PloS one.

[138]  J. Norris,et al.  Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening , 2003, Pediatric pulmonology.

[139]  J. Davies,et al.  Recent advances in the management of cystic fibrosis , 2014, Archives of Disease in Childhood.

[140]  M. Surette,et al.  Cystic fibrosis: a polymicrobial infectious disease. , 2006, Future microbiology.

[141]  D. Meyerholz Lessons learned from the cystic fibrosis pig. , 2016, Theriogenology.

[142]  K. Lewis,et al.  Persister cells. , 2010, Annual review of microbiology.

[143]  D. Geddes,et al.  Airway surface pH in subjects with cystic fibrosis , 2003, European Respiratory Journal.

[144]  D. Borowitz CFTR, bicarbonate, and the pathophysiology of cystic fibrosis , 2015, Pediatric pulmonology.

[145]  P. Russo,et al.  Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate. , 2016, Journal of aerosol medicine and pulmonary drug delivery.

[146]  Sharon L. Grim,et al.  Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis , 2014, Microbiome.

[147]  Haitao Wen,et al.  The inflammasome NLRs in immunity, inflammation, and associated diseases. , 2011, Annual review of immunology.

[148]  S. Leroy,et al.  The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management , 2012, PloS one.

[149]  N. Høiby,et al.  Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. , 1992, Thorax.

[150]  G. Gargala,et al.  Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients , 2016, Journal of Clinical Microbiology.

[151]  Ajit Varki,et al.  Acidic pH increases airway surface liquid viscosity in cystic fibrosis. , 2016, The Journal of clinical investigation.

[152]  Jinglan Zhou,et al.  Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 , 2009, Proceedings of the National Academy of Sciences.

[153]  N. Høiby,et al.  Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre. , 1995, The Journal of hospital infection.

[154]  M. Maciá,et al.  The problems of antibiotic resistance in cystic fibrosis and solutions , 2015, Expert review of respiratory medicine.

[155]  Forest Rohwer,et al.  Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung , 2014, mBio.

[156]  G. Cutting,et al.  Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. , 2010, The Journal of pediatrics.

[157]  D. Stevens,et al.  Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center , 2016, Antimicrobial Agents and Chemotherapy.

[158]  F. Taddei,et al.  Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis , 2009, Pediatric pulmonology.

[159]  Xiaohong Huang,et al.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. , 2015, The New England journal of medicine.

[160]  Andrea M. Smania,et al.  Coexistence and Within-Host Evolution of Diversified Lineages of Hypermutable Pseudomonas aeruginosa in Long-term Cystic Fibrosis Infections , 2014, PLoS genetics.

[161]  D. Willner,et al.  Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[162]  A. Gaggar,et al.  Innate immunity in cystic fibrosis lung disease. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[163]  S. Rand,et al.  Exercise as part of a cystic fibrosis therapeutic routine , 2012, Expert review of respiratory medicine.

[164]  L. Delhaes,et al.  Fungal respiratory infections in cystic fibrosis: a growing problem. , 2010, Medical mycology.

[165]  C. Wielinski,et al.  Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. , 1993, The Journal of pediatrics.

[166]  G. Rogers,et al.  Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition , 2013, Thorax.

[167]  Eric P. Skaar,et al.  Iron in infection and immunity. , 2013, Cell host & microbe.

[168]  J. Clancy Cystic Fibrosis Transmembrane Conductance Regulator Function in Airway Smooth Muscle. A Novel Role in Cystic Fibrosis Airway Obstruction. , 2016, American journal of respiratory and critical care medicine.

[169]  Jace W. Jones,et al.  Iron Depletion Enhances Production of Antimicrobials by Pseudomonas aeruginosa , 2015, Journal of bacteriology.

[170]  C. Férec,et al.  Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France , 2012, Orphanet Journal of Rare Diseases.

[171]  George P Patrinos,et al.  Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene , 2013, Nature Genetics.

[172]  Richard C Boucher,et al.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.

[173]  Y. Berthiaume,et al.  Regulation of ENaC and CFTR expression with K+ channel modulators and effect on fluid absorption across alveolar epithelial cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[174]  G. Giebisch,et al.  CFTR is required for PKA-regulated ATP sensitivity of Kir1.1 potassium channels in mouse kidney. , 2006, The Journal of clinical investigation.

[175]  H. Hoogsteden,et al.  Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. , 2014, The Lancet. Respiratory medicine.

[176]  H. Forman,et al.  Abnormal glutathione transport in cystic fibrosis airway epithelia. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[177]  D. Wat,et al.  The role of respiratory viruses in cystic fibrosis , 2008, Journal of Cystic Fibrosis.

[178]  K. Du,et al.  Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function , 2012, Cell.

[179]  H. Ackermann,et al.  Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease , 2006, Journal of Clinical Microbiology.

[180]  Morgan L. Maeder,et al.  Genome-editing Technologies for Gene and Cell Therapy , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[181]  C. Higgins,et al.  Immunocytochemical localization of the cystic fibrosis gene product CFTR. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[182]  A. Fodor,et al.  The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations , 2012, PloS one.

[183]  M. Surette,et al.  Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication , 2003, Molecular microbiology.

[184]  P. Diot,et al.  Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. , 2012, American journal of respiratory cell and molecular biology.

[185]  J. Gatzy,et al.  Acetylcholine-induced liquid secretion by bronchial epithelium: role of Cl- and[Formula: see text] transport. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[186]  A. Oliver,et al.  Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[187]  Andrew M. Jones,et al.  The Microbiome and Emerging Pathogens in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis , 2015, Seminars in Respiratory and Critical Care Medicine.

[188]  J. Gatzy,et al.  Acetylcholine-induced liquid secretion by bronchial epithelium: role of Cl- and HCO3- transport. , 1998, The American journal of physiology.

[189]  Zaid Abdo,et al.  The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation , 2015, Microbiome.

[190]  Forest Rohwer,et al.  Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals , 2009, PloS one.

[191]  K. Lewis Persister cells: molecular mechanisms related to antibiotic tolerance. , 2012, Handbook of Experimental Pharmacology.

[192]  H. Malech,et al.  Release of Cystic Fibrosis Airway Inflammatory Markers from Pseudomonas aeruginosa–Stimulated Human Neutrophils Involves NADPH Oxidase-Dependent Extracellular DNA Trap Formation , 2014, The Journal of Immunology.

[193]  M. Wolfgang,et al.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.

[194]  B. Harvey,et al.  Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[195]  David J. Evans,et al.  Pseudomonas aeruginosa-Induced Bleb-Niche Formation in Epithelial Cells Is Independent of Actinomyosin Contraction and Enhanced by Loss of Cystic Fibrosis Transmembrane-Conductance Regulator Osmoregulatory Function , 2015, mBio.

[196]  J. Heesemann,et al.  Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. , 2013, Current topics in microbiology and immunology.

[197]  J. Jansson,et al.  Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization , 2015, SpringerPlus.

[198]  Lucas Smith,et al.  Phenotypic Characterization of Clonal and Nonclonal Pseudomonas aeruginosa Strains Isolated from Lungs of Adults with Cystic Fibrosis , 2007, Journal of Clinical Microbiology.

[199]  Rosemary C. She,et al.  Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa. , 2016, The Journal of antimicrobial chemotherapy.

[200]  N. Høiby,et al.  Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. , 1983, The Journal of hospital infection.

[201]  L. Reid,et al.  Ultrastructure of cells in the human bronchial submucosal glands. , 1970, Journal of anatomy.

[202]  Meenu Singh,et al.  CD4+CD25 high FOXP3+ Regulatory T Cells Correlate with FEV1 in North Indian Children with Cystic Fibrosis , 2014, Immunological investigations.

[203]  Hans Clevers,et al.  A functional CFTR assay using primary cystic fibrosis intestinal organoids , 2013, Nature Medicine.

[204]  I. Crandall,et al.  Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. , 2011, American journal of respiratory and critical care medicine.

[205]  D. Gadsby,et al.  Strict coupling between CFTR’s catalytic cycle and gating of its Cl− ion pore revealed by distributions of open channel burst durations , 2009, Proceedings of the National Academy of Sciences.

[206]  G. Nagel,et al.  Non‐specific activation of the epithelial sodium channel by the CFTR chloride channel , 2001, EMBO reports.

[207]  M. Knowles,et al.  Evidence for reduced Cl‐ and increased Na+ permeability in cystic fibrosis human primary cell cultures. , 1988, The Journal of physiology.

[208]  V. Waters,et al.  Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. , 2014, Annals of the American Thoracic Society.

[209]  S. McColley,et al.  Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis , 2011, Clinical Microbiology Reviews.

[210]  G. Huffnagle,et al.  The bacterial microbiota in inflammatory lung diseases. , 2015, Clinical immunology.

[211]  S. Lewis,et al.  Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[212]  Garth D. Ehrlich,et al.  Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms , 2004, Antimicrobial Agents and Chemotherapy.

[213]  P. Leprohon,et al.  Diverse Virulent Pneumophages Infect Streptococcus mitis , 2015, PloS one.

[214]  S. Leeper-Woodford,et al.  Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-κB expression. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[215]  C. Merlo,et al.  Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.

[216]  M. Surette,et al.  McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients. , 2010, Journal of medical microbiology.

[217]  Christian Koch,et al.  Early infection and progression of cystic fibrosis lung disease , 2002, Pediatric pulmonology.

[218]  David K. Meyerholz,et al.  Airway acidification initiates host defense abnormalities in cystic fibrosis mice , 2016, Science.

[219]  Jordi Villà-Freixa,et al.  New Model of Cystic Fibrosis Transmembrane Conductance Regulator Proposes Active Channel-like Conformation , 2012, J. Chem. Inf. Model..

[220]  M. Welsh,et al.  Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[221]  J. Parkhill,et al.  Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention , 2015, The ISME Journal.

[222]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[223]  Karen A Robinson,et al.  Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. , 2007, American journal of respiratory and critical care medicine.

[224]  Szilvia Szép,et al.  The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases , 2009, Proceedings of the National Academy of Sciences.

[225]  E. Schwiebert,et al.  Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells. , 1995, The American journal of physiology.

[226]  A. Prince,et al.  Cystic fibrosis: a mucosal immunodeficiency syndrome , 2012, Nature Medicine.

[227]  M. Knowles,et al.  Mucus clearance and lung function in cystic fibrosis with hypertonic saline. , 2006, The New England journal of medicine.

[228]  P. Thomas,et al.  CFTR and Cystic Fibrosis , 2015 .

[229]  James M. Wilson,et al.  Submucosal glands are the predominant site of CFTR expression in the human bronchus , 1992, Nature Genetics.

[230]  L. Lynd,et al.  Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model , 2015, Journal of bacteriology.

[231]  M. Surette,et al.  Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing? , 2015, Annals of the American Thoracic Society.

[232]  S. McGrath-Morrow,et al.  Environmental Research and Public Health the Impact of Secondhand Smoke Exposure on Children with Cystic Fibrosis: a Review , 2022 .

[233]  A. Amer,et al.  IFN-γ Stimulates Autophagy-Mediated Clearance of Burkholderia cenocepacia in Human Cystic Fibrosis Macrophages , 2014, PloS one.

[234]  J. Stockman Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa: A Randomized Controlled Trial , 2012 .

[235]  Roger Marthan,et al.  Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis. , 2007, Radiology.

[236]  M. Surette,et al.  The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. , 2011, Canadian journal of microbiology.

[237]  T. Yamaguchi,et al.  Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. , 1999, American journal of respiratory and critical care medicine.